BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30446315)

  • 1. Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.
    Post CCB; Kramer MCA; Smid EJ; van der Weide HL; Kleynen CE; Heesters MAAM; Verhoeff JJC
    Radiother Oncol; 2019 Jan; 130():156-163. PubMed ID: 30446315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an established prognostic score after re-irradiation of recurrent glioma.
    Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Meyer B; Combs SE
    Acta Oncol; 2017 Mar; 56(3):422-426. PubMed ID: 28075197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
    Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L; Falkov A; Chelimo C; Fogh SE
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
    Lee J; Cho J; Chang JH; Suh CO
    Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
    Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
    J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
    Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
    Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
    Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
    Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).
    Lévy S; Chapet S; Scher N; Debbi K; Ruffier A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2017 Dec; 21(8):759-765. PubMed ID: 29128197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
    Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
    J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
    Combs SE; Niyazi M; Adeberg S; Bougatf N; Kaul D; Fleischmann DF; Gruen A; Fokas E; Rödel CM; Eckert F; Paulsen F; Oehlke O; Grosu AL; Seidlitz A; Lattermann A; Krause M; Baumann M; Guberina M; Stuschke M; Budach V; Belka C; Debus J; Kessel KA
    Cancer Med; 2018 May; 7(5):1742-1749. PubMed ID: 29573214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability.
    Combs SE; Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Gempt J; Meyer B
    Neurosurgery; 2018 Dec; 83(6):1241-1248. PubMed ID: 29462372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort.
    Niyazi M; Flieger M; Ganswindt U; Combs SE; Belka C
    Radiat Oncol; 2014 Jun; 9():128. PubMed ID: 24893775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
    Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
    Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.
    Bartsch R; Weitmann HD; Pennwieser W; Wenzel C; Muschitz S; Baldass M; Hassler M; Marosi C; Rössler K; Pötter R; Dieckmann K
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):821-6. PubMed ID: 16437319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation.
    Müller K; Henke G; Compter I; von Bueren AO; Friedrich C; Janssens G; Kramm CM; Hundsberger T; Paulsen F; Kortmann RD; Zwiener I; Baumert BG
    Pract Radiat Oncol; 2015; 5(3):e143-e150. PubMed ID: 25424325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.